Here's what we're tracking on the RWI podcast.

A new Delta ‘Plus’ variant of the coronavirus, which is said to be driving a surge in Covid-19 cases in the UK, has shown up in India.

The World Health Organization’s technical advisory group will meet tomorrow to decide on granting emergency use listing (EUL) to Bharat Biotech’s Covid-19 vaccine Covaxin.

The ongoing quarterly earnings will be the major factor driving market trends going ahead, and benchmark indices may face volatility this week. Foreign portfolio investors have turned net sellers in India by pulling out Rs 3,825 crore in October so far.

Watch out for earnings reaction to ICICI Bank, RIL among others.